Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repair

被引:36
作者
Ye, Lei [1 ]
Zhang, Wei [2 ]
Su, Li-Ping [3 ]
Haider, Husnain K. [4 ]
Poh, Kian-Keong [5 ,6 ]
Galupo, Mary J. [5 ]
Songco, Geronica [5 ]
Ge, Ruo-Wen [7 ]
Tan, Huay-Cheem [5 ,6 ]
Sim, Eugene K. W. [8 ,9 ]
机构
[1] Natl Univ Singapore, Natl Univ Med Inst, Cardiovasc Res Inst, Singapore 117597, Singapore
[2] Natl Univ Singapore, Dept Pharmacol, Singapore 117597, Singapore
[3] Natl Univ Singapore, Div Bioengn, Singapore 117597, Singapore
[4] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA
[5] Natl Univ Heart Ctr, Dept Cardiac, Singapore, Singapore
[6] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore
[7] Natl Univ Singapore, Dept Biol Sci, Singapore 117597, Singapore
[8] Mt Elizabeth Med Ctr, Singapore, Singapore
[9] Gleneagles JPMC Cardiac Ctr, Bandar Seri Begawan, Brunei
关键词
Skeletal myoblast; Hypoxia; VEGF; Myocardial infarction; Cardiac repair; ENDOTHELIAL GROWTH FACTOR-165; SKELETAL MYOBLAST; GENE-EXPRESSION; NONVIRAL VECTOR; CARDIAC REPAIR; ISCHEMIC-HEART; TRANSFECTION; POLYETHYLENIMINE; ANGIOGENESIS; EFFICIENCY;
D O I
10.1016/j.biomaterials.2010.12.008
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A regulated promoter system to control gene expression is desirable for safe and efficacious overexpression of therapeutic transgene. Combined with skeletal myoblast (SkMs), we report the efficacy of hypoxia-regulated VEGF gene delivery for myocardial repair during acute myocardial infarction (AM!). A hypoxia-regulated VEGF plasmid (pHRE-VEGF) was developed. After optimization, similar to 30% SkMs were transfected using polyethyleneimine (PEI) nanoparticles. The peak VEGF expression was higher in pHRE-VEGF transfected SkMs ((VEGF)SkMs) under hypoxia (151.34 +/- 8.59 ng/ml) than that with normoxia (16.92 +/- 2.74 ng/ml). The efficacy of hypoxia-regulated gene expression system was assessed in a rabbit model of AMI. The animals were grouped to receive basal M199 without cells (group-1) or containing non-transfected SkMs (group-2) or (VEGF)SkMs (group-3). In group-4, (VEGF)SkMs were injected into normal heart to serve as normoxia control. Improved SkM survival was observed in group-3 and -4 (p < 0.05 vs group-2) at day-3 and 7 after transplantation. Blood vessel density was 20.1 +/- 1.3 in group-3 which was significantly higher than any other groups (p < 0.05) at 2 weeks after treatment. Improved blood flow (ml/min/g) in the left ventricle (LV) anterior wall was observed in group-3 (1.28 +/- 0.09, p < 0.05) as compared with group-1 (0.76 +/- 0.05) and group-2 (0.96 +/- 0.06), and similar to group-4 (1.26 +/- 0.05). LV ejection fraction was best preserved in group-3 (58.4 +/- 1.75%) which was insignificantly different from group-4 (61.1 +/- 1.8%), and group-2 (52.8 +/- 1.4%), but significantly improved compared with group-1 (44.7 +/- 2.2%, p < 0.05). The study demonstrates that nanoparticle based delivery of hypoxia-regulated VEGF transgene combined with SkMs during AMI effectively preserves LV regional blood flow and contractile function of the heart. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2424 / 2431
页数:8
相关论文
共 20 条
  • [1] Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector
    Bohl, D
    Salvetti, A
    Moullier, P
    Heard, JM
    [J]. BLOOD, 1998, 92 (05) : 1512 - 1517
  • [2] Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles
    Bouchentouf, M.
    Benabdallah, B. F.
    Bigey, P.
    Yau, T. M.
    Scherman, D.
    Tremblay, J. P.
    [J]. GENE THERAPY, 2008, 15 (06) : 404 - 414
  • [3] A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine:: Effect of molecular weight on transfection efficiency and cytotoxicity
    Fischer, D
    Bieber, T
    Li, YX
    Elsässer, HP
    Kissel, T
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (08) : 1273 - 1279
  • [4] Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette
    Hofmann, A
    Nolan, GP
    Blau, HM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) : 5185 - 5190
  • [5] Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency
    Kreiss, P
    Cameron, B
    Rangara, R
    Mailhe, P
    Aguerre-Charriol, O
    Airiau, M
    Scherman, D
    Crouzet, J
    Pitard, B
    [J]. NUCLEIC ACIDS RESEARCH, 1999, 27 (19) : 3792 - 3798
  • [6] Lee RJ, 2000, CIRCULATION, V102, P898
  • [7] Polyethylenimine-based non-viral gene delivery systems
    Lungwitz, U
    Breunig, M
    Blunk, T
    Göpferich, A
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (02) : 247 - 266
  • [8] Regulation of angiogenesis by hypoxia: role of the HIF system
    Pugh, CW
    Ratcliffe, PJ
    [J]. NATURE MEDICINE, 2003, 9 (06) : 677 - 684
  • [9] RECOMMENDATIONS REGARDING QUANTITATION IN M-MODE ECHOCARDIOGRAPHY - RESULTS OF A SURVEY OF ECHOCARDIOGRAPHIC MEASUREMENTS
    SAHN, DJ
    DEMARIA, A
    KISSLO, J
    WEYMAN, A
    [J]. CIRCULATION, 1978, 58 (06) : 1072 - 1083
  • [10] Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes
    Shibata, T
    Akiyama, N
    Noda, M
    Sasai, K
    Hiraoka, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04): : 913 - 916